‡ Lipper is an industry research firm whose rankings are based on total return performance, vary over time, and do not reflect the effects of sales charges. Past performance is not indicative of future results.
Putnam Allstate Advisor Plus
Putnam Global Health Care Subaccount
The subaccount seeks capital appreciation.
Fund description
The subaccount seeks to capitalize on the strength of the health-care sector, targeting companies of all sizes. Holdings encompass an array of industries, including pharmaceuticals, health-care services, and biotechnology. The fund seeks companies that offer strong long-term growth prospects, regardless of their size.
Sales story
Investing in the health-care sectorA dynamic sectorFrom biotech and drugs to devices and hospitals, the fund invests in industries that can profit from the global demand for health-care products and services.Seeks growth from innovationInnovative health-care solutions are always in demand, giving the fund potential for positive returns regardless of economic conditions.Active managementSupported by experienced research analysts, the portfolio manager uses bottom-up research to assess scientific innovation, regulatory changes, and company fundamentals.
Management team
- Michael J. Maguire, CFA (Investing since 2002)
Daily pricing as of 08/02/21
| with optional enhanced death benefits | ||
|---|---|---|
| Unit Value | $34.733059 | $33.618849 |
| Unit Value Change | 0.135971 | 0.131197 |
Quick facts as of 06/30/21
| Fiscal Year End | December |
| Asset Class | Putnam Allstate Advisor Plus |
| Subaccount Status | Open to new investors |
| Number of issues | 65 |
| Turnover (fiscal year end) | 82% |
| Net Assets | $165M |
| Inception Date | 04/30/98 |
Performance
Performance as of 06/30/21
| Annualized Performance | Last Quarter | Year to Date |
1 yr. | 3 yrs. | 5 yrs. | 10 yrs. | Life of subaccount |
|---|---|---|---|---|---|---|---|
| Restated performance | |||||||
| Unit Value | 6.61% | 7.03% | 20.70% | 14.32% | 10.63% | 11.48% | 6.10% |
| Standardized | -1.39% | -0.97% | 12.70% | 12.24% | 9.82% | 11.48% | 6.10% |
| With optional enhanced death benefit | |||||||
| Unit Value | 6.57% | 6.95% | 20.52% | 14.14% | 10.47% | 11.31% | 5.94% |
| Standardized | -1.43% | -1.05% | 12.52% | 12.06% | 9.65% | 11.31% | 5.94% |
| Actual performance | |||||||
| Unit Value | 6.61% | 7.03% | 20.70% | 14.32% | 10.63% | 11.48% | 5.65% |
| Standardized | -1.39% | -0.97% | 12.70% | 12.24% | 9.82% | 11.48% | 5.65% |
| With optional enhanced death benefit | |||||||
| Unit Value | 6.57% | 6.95% | 20.52% | 14.14% | 10.47% | 11.31% | 5.49% |
| Standardized | -1.43% | -1.05% | 12.52% | 12.06% | 9.65% | 11.31% | 5.49% |
Annual Performance at NAV
| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|---|---|---|---|
| -2.76% | 20.31% | 39.40% | 25.60% | 6.06% | -12.77% | 13.46% | -2.19% | 28.21% | 14.42% |
| With optional enhanced death benefit | |||||||||
| -2.90% | 20.12% | 39.19% | 25.41% | 5.90% | -12.90% | 13.29% | -2.34% | 28.02% | 14.25% |
Restated performance
Monthly as of 07/31/21 |
|
|---|---|
| Unit Value | 2.00% |
| Standardized | -6.00% |
YTD as of 08/02/21 |
|
|---|---|
| Unit Value | 9.60% |
| Standardized | 1.60% |
With optional enhanced death benefit
Monthly as of 07/31/21 |
|
|---|---|
| Unit Value | 1.99% |
| Standardized | -6.01% |
YTD as of 08/02/21 |
|
|---|---|
| Unit Value | 9.50% |
| Standardized | 1.50% |
Unit values and performance information shown apply to the specific annuity product listed, not the underlying Putnam Variable Trust fund. This information should not be used by investors who hold an interest in Putnam Variable Trust funds through a different annuity or other variable product. The unit values and performance of other variable products that offer Putnam Variable Trust funds may be higher or lower due to product charges and expenses or other factors.
Data is historical. Past performance is no guarantee of future results. More recent returns may be less or more than those shown. Investment return and principal value will fluctuate, and you may have a gain or a loss when you sell your units.
Returns shown for the subaccounts for periods before their inception are derived from the historical performance of the underlying fund, adjusted to reflect the mortality, expense risk, and surrender charges applicable to this product and do not factor in the annual $30 contract maintenance fee. Additional riders and options for insurance-related charges will increase expenses and lower returns. Please see the prospectus for details. For a portion of the period, subaccounts may have limited expenses, without which returns would have been lower.
Variable annuities are long-term investments designed for retirement purposes. Putnam Capital Manager products are flexible-premium variable annuities held by Talcott Resolution Life, Inc., Simsbury, CT.
Putnam Allstate variable annuities are flexible-premium deferred variable annuities issued by Allstate Life Insurance Company (Allstate Life); underwritten by Allstate Distributors, L.L.C., both of Northbrook, IL; and sold through registered representatives or bank employees who are licensed insurance agents. Please check for availability in your specific state.
These policies have limitations and are sold by prospectus only. The prospectus contains details on the variable annuity, the subaccounts, contract features, fees, expenses, and other pertinent information.
Investors should carefully consider the investment objectives, risks, charges, and expenses of a fund before investing. For a prospectus containing this and other information for any variable annuity or variable life product that invests in Putnam Variable Trust funds, contact your financial advisor for a contract prospectus and prospectus for the underlying funds. You may also call Talcott Resolution at 1-800-521-0538 or Allstate at 1-800-390-1277. Read the prospectuses carefully before investing.
For the most recent month-end performance, please call Talcott Resolution at 1-800-521-0538 or Allstate at 1-800-390-1277.
Risk Characteristics as of 06/30/21
| Alpha (%) | 0.83 |
| Beta | 0.97 |
| R Squared | 0.95 |
| Standard Deviation (3 yrs.) | 14.84 |
Holdings
| UnitedHealth Group | 6.85% |
| Astrazeneca | 5.83% |
| Johnson & Johnson | 5.20% |
| Abbvie | 4.70% |
| Danaher Corp | 4.12% |
| Eli Lilly | 4.06% |
| Thermo Fisher Scientific | 3.90% |
| Sanofi | 3.18% |
| Ironwood Pharmaceuticals | 3.08% |
| Roche Holding Ag | 2.91% |
| Top 10 holdings, total: | 43.83% |
| Top 10 holdings as of 06/30/21 | |
|---|---|
| 1: UnitedHealth Group | 6.85% |
| 2: Astrazeneca | 5.83% |
| 3: Johnson & Johnson | 5.20% |
| 4: Abbvie | 4.70% |
| 5: Danaher Corp | 4.12% |
| 6: Eli Lilly | 4.06% |
| 7: Thermo Fisher Scientific | 3.90% |
| 8: Sanofi | 3.18% |
| 9: Ironwood Pharmaceuticals | 3.08% |
| 10: Roche Holding Ag | 2.91% |
| Holdings represent 43.83% of portfolio | |
| Top 10 holdings as of 05/31/21 | |
|---|---|
| 1: UnitedHealth Group | 7.12% |
| 2: Astrazeneca | 5.76% |
| 3: Abbvie | 5.42% |
| 4: Johnson&Johnson | 5.40% |
| 5: Eli Lilly | 4.41% |
| 6: Thermo Fisher Scientific | 3.67% |
| 7: Danaher Corp | 3.44% |
| 8: Sanofi | 3.29% |
| 9: Roche Holding Ag | 3.08% |
| 10: Medtronic | 3.00% |
| Holdings represent 44.59% of portfolio | |
| Top 10 holdings as of 04/30/21 | |
|---|---|
| 1: UnitedHealth Group | 6.97% |
| 2: Astrazeneca | 5.88% |
| 3: Abbvie | 5.40% |
| 4: Johnson&Johnson | 5.25% |
| 5: Eli Lilly | 4.08% |
| 6: Danaher Corp | 3.45% |
| 7: Sanofi | 3.25% |
| 8: Thermo Fisher Scientific | 3.20% |
| 9: Medtronic | 3.14% |
| 10: Roche Holding Ag | 2.89% |
| Holdings represent 43.51% of portfolio | |
| Top 10 holdings as of 03/31/21 | |
|---|---|
| 1: UnitedHealth Group | 6.70% |
| 2: Abbvie | 5.60% |
| 3: Johnson Johnson | 5.46% |
| 4: Astrazeneca | 5.46% |
| 5: Eli Lilly And | 4.29% |
| 6: Thermo Fisher Scientific | 3.20% |
| 7: Danaher Corp | 3.15% |
| 8: Roche Holding Ag | 2.96% |
| 9: Medtronic | 2.92% |
| 10: Sanofi | 2.73% |
| Holdings represent 42.47% of portfolio | |
| UNITEDHEALTH GROUP INC SEDOL 2917766 | 6.85% | ASTRAZENECA PLC SEDOL 0989529 | 5.82% | JOHNSON & JOHNSON SEDOL 2475833 | 5.20% | ABBVIE INC SEDOL B92SR70 | 4.70% | DANAHER CORP SEDOL 2250870 | 4.12% | ELI LILLY & CO SEDOL 2516152 | 4.06% | THERMO FISHER SCIENTIFIC INC SEDOL 2886907 | 3.90% | SANOFI SEDOL 5671735 | 3.18% | IRONWOOD PHARMACEUTICALS INC SEDOL B3MZ6K5 | 3.08% | ROCHE HOLDING AG-GENUSSCHEIN SEDOL 7110388 | 2.91% | ABBOTT LABORATORIES SEDOL 2002305 | 2.84% | ANTHEM INC SEDOL BSPHGL4 | 2.68% | PFIZER INC SEDOL 2684703 | 2.52% | INNOVIVA INC SEDOL BDDXF67 | 2.46% | MERCK & CO. INC. SEDOL 2778844 | 2.41% | ASCENDIS PHARMA A/S - ADR SEDOL BV9G6B8 | 2.38% | MEDTRONIC PLC SEDOL BTN1Y11 | 2.32% | EDWARDS LIFESCIENCES CORP SEDOL 2567116 | 2.10% | BIOGEN INC SEDOL 2455965 | 2.08% | ICON PLC SEDOL B94G471 | 1.90% | NOVARTIS AG-REG SEDOL 7103065 | 1.82% | BRISTOL-MYERS SQUIBB CO SEDOL 2126335 | 1.65% | LONZA GROUP AG-REG SEDOL 7333378 | 1.46% | MCKESSON CORP SEDOL 2378534 | 1.38% | REGENERON PHARMACEUTICALS SEDOL 2730190 | 1.33% | BIO-RAD LABORATORIES-A SEDOL 2098508 | 1.28% | GLAXOSMITHKLINE PLC SEDOL 0925288 | 1.12% | SARISSA CAPITAL ACQUISITION SEDOL BMF7JF7 | 1.08% | NOVO NORDISK A/S-B SEDOL BHC8X90 | 1.02% | ACCELERON PHARMA INC SEDOL BDGTXQ8 | 1.01% | INTUITIVE SURGICAL INC SEDOL 2871301 | 1.00% | NOVAVAX INC SEDOL BJDQXG4 | 0.98% | MERCK KGAA SEDOL 4741844 | 0.95% | UNITED THERAPEUTICS CORP SEDOL 2430412 | 0.90% | 4FRONT VENTURES CORP SEDOL BKFGXD6 | 0.84% | HUMANA INC SEDOL 2445063 | 0.80% | AMERISOURCEBERGEN CORP | 0.79% | TAKEDA PHARMACEUTICAL CO LTD SEDOL 6870445 | 0.76% | GILEAD SCIENCES INC SEDOL 2369174 | 0.68% | CIGNA CORP SEDOL BHJ0775 | 0.64% | TERRASCEND CORP SEDOL BDFDQ73 | 0.63% | ALKERMES PLC SEDOL B3P6D26 | 0.58% | MIRATI THERAPEUTICS INC SEDOL BBPK0J0 | 0.52% | DAIICHI SANKYO CO LTD SEDOL B0J7D91 | 0.51% | ASTELLAS PHARMA INC SEDOL 6985383 | 0.50% | INMODE LTD SEDOL BK5Z9R9 | 0.50% | TURNING POINT THERAPEUTICS I SEDOL BJXBP30 | 0.49% | ROCKET PHARMACEUTICALS INC SEDOL BDFKQ07 | 0.47% | ZIMMER BIOMET HOLDINGS INC SEDOL 2783815 | 0.46% | HEALTH SCIENCES ACQUISITIONS SEDOL BMWWF91 | 0.42% | CHUGAI PHARMACEUTICAL CO LTD SEDOL 6196408 | 0.38% | LABORATORY CRP OF AMER HLDGS SEDOL 2586122 | 0.37% | TERUMO CORP SEDOL 6885074 | 0.36% | EISAI CO LTD SEDOL 6307200 | 0.35% | VOR BIOPHARMA INC SEDOL BLCD876 | 0.29% | GREEN THUMB INDUSTRIES INC SEDOL BFFY829 | 0.25% | TG THERAPEUTICS INC SEDOL B828K63 | 0.23% | SYNDAX PHARMACEUTICALS INC SEDOL BN7Q7R7 | 0.20% | TRULIEVE CANNABIS CORP SEDOL BGNKTH8 | 0.19% | VINCERX PHARMA INC SEDOL BNGJR22 | 0.16% | EUR/USD 09/15/2021 HSBCB | 0.07% | CASH MGMT BILL 00.0000 09/07/2021 | 0.06% | GBP/USD 09/15/2021 WPAC | 0.05% | EUR/USD 09/15/2021 MSCIL | 0.05% | COLUMBIA CARE INC SEDOL BJYS701 | 0.04% | GBP/USD 09/15/2021 SSBT | 0.03% | EUR/USD 09/15/2021 GSFX | 0.03% | GBP/USD 09/15/2021 CSI-FX | 0.02% | DKK/USD 09/15/2021 BANKAM | 0.02% | JPY/USD 08/18/2021 BANKAM | 0.02% | JPY/USD 08/18/2021 JPMCB | 0.02% | GBP/USD 09/15/2021 BANKAM | 0.01% | EUR/USD 09/15/2021 CITI | 0.01% | GBP/USD 09/15/2021 BCAP-FX | 0.01% | CAD/USD 07/21/2021 HSBCB | 0.00% | EUR/USD 09/15/2021 SSBT | 0.00% | NEURALSTEM INC SERIES K COMMON STOCK PURCHASE WARRANT | 0.00% | AUD/USD 07/21/2021 BANKAM | -0.00% | JPY/USD 08/18/2021 SSBT | -0.00% | NZD/USD 07/21/2021 JPMCB | -0.00% | CHF/USD 09/15/2021 BANKAM | -0.00% | ILS/USD 07/21/2021 SSBT | -0.00% | JPY/USD 08/18/2021 BCAP-FX | -0.00% | EUR/USD 09/15/2021 WPAC | -0.00% | CAD/USD 07/21/2021 SSBT | -0.00% | EUR/USD 09/15/2021 TDBK | -0.01% | JPY/USD 08/18/2021 UBS | -0.01% | GBP/USD 09/15/2021 HSBCB | -0.01% | JPY/USD 08/18/2021 CSI-FX | -0.01% | EUR/USD 09/15/2021 BCAP-FX | -0.01% | EUR/USD 09/15/2021 UBS | -0.01% | DKK/USD 09/15/2021 CITI | -0.02% | GBP/USD 09/15/2021 GSFX | -0.02% | GBP/USD 09/15/2021 MSCIL | -0.02% | AUD/USD 07/21/2021 RBSF | -0.03% | EUR/USD 09/15/2021 RBSF | -0.03% | JPY/USD 08/18/2021 GSFX | -0.04% | CHF/USD 09/15/2021 HSBCB | -0.06% | EUR/USD 09/15/2021 BANKAM | -0.09% |
| UNITEDHEALTH GROUP INC SEDOL 2917766 | 6.70% | ABBVIE INC SEDOL B92SR70 | 5.60% | JOHNSON & JOHNSON SEDOL 2475833 | 5.46% | ASTRAZENECA PLC SEDOL 0989529 | 5.46% | ELI LILLY & CO SEDOL 2516152 | 4.29% | THERMO FISHER SCIENTIFIC INC SEDOL 2886907 | 3.20% | DANAHER CORP SEDOL 2250870 | 3.15% | ROCHE HOLDING AG-GENUSSCHEIN SEDOL 7110388 | 2.96% | MEDTRONIC PLC SEDOL BTN1Y11 | 2.92% | SANOFI SEDOL 5671735 | 2.73% | ANTHEM INC SEDOL BSPHGL4 | 2.65% | PFIZER INC SEDOL 2684703 | 2.59% | MERCK & CO. INC. SEDOL 2778844 | 2.52% | GLAXOSMITHKLINE PLC SEDOL 0925288 | 2.40% | NOVARTIS AG-REG SEDOL 7103065 | 2.38% | IRONWOOD PHARMACEUTICALS INC SEDOL B3MZ6K5 | 2.19% | ICON PLC SEDOL B94G471 | 2.16% | ABBOTT LABORATORIES SEDOL 2002305 | 2.09% | EDWARDS LIFESCIENCES CORP SEDOL 2567116 | 1.79% | REGENERON PHARMACEUTICALS SEDOL 2730190 | 1.76% | BRISTOL-MYERS SQUIBB CO SEDOL 2126335 | 1.64% | MCKESSON CORP SEDOL 2378534 | 1.63% | DAIICHI SANKYO CO LTD SEDOL B0J7D91 | 1.43% | ACCELERON PHARMA INC SEDOL BDGTXQ8 | 1.33% | LONZA GROUP AG-REG SEDOL 7333378 | 1.28% | BIO-RAD LABORATORIES-A SEDOL 2098508 | 1.20% | SARISSA CAPITAL ACQUISITION SEDOL BMF7JF7 | 1.20% | INNOVIVA INC SEDOL BDDXF67 | 1.15% | HUMANA INC SEDOL 2445063 | 1.09% | ZIMMER BIOMET HOLDINGS INC SEDOL 2783815 | 1.03% | AVANTOR INC SEDOL BJLT387 | 1.02% | BIOGEN INC SEDOL 2455965 | 0.92% | MERCK KGAA SEDOL 4741844 | 0.89% | TAKEDA PHARMACEUTICAL CO LTD SEDOL 6870445 | 0.87% | NOVO NORDISK A/S-B SEDOL BHC8X90 | 0.86% | AMERISOURCEBERGEN CORP | 0.86% | INTUITIVE SURGICAL INC SEDOL 2871301 | 0.85% | VERTEX PHARMACEUTICALS INC SEDOL 2931034 | 0.83% | 4FRONT VENTURES CORP SEDOL BKFGXD6 | 0.70% | VOR BIOPHARMA INC SEDOL BLCD876 | 0.70% | CIGNA CORP SEDOL BHJ0775 | 0.69% | MERSANA THERAPEUTICS INC SEDOL BF3NP05 | 0.69% | ALNYLAM PHARMACEUTICALS INC SEDOL B00FWN1 | 0.68% | LABORATORY CRP OF AMER HLDGS SEDOL 2586122 | 0.63% | TERUMO CORP SEDOL 6885074 | 0.58% | VINCERX PHARMA INC SEDOL BNGJR22 | 0.58% | PERRIGO CO PLC SEDOL BGH1M56 | 0.55% | AMGEN INC SEDOL 2023607 | 0.55% | INMODE LTD SEDOL BK5Z9R9 | 0.51% | BAUSCH HEALTH COS INC SEDOL BFFVVC1 | 0.51% | BLUEPRINT MEDICINES CORP SEDOL BWY52P3 | 0.51% | UNITED THERAPEUTICS CORP SEDOL 2430412 | 0.50% | HEALTH SCIENCES ACQUISITIONS SEDOL BMWWF91 | 0.49% | ROCKET PHARMACEUTICALS INC SEDOL BDFKQ07 | 0.49% | TERRASCEND CORP SEDOL BDFDQ73 | 0.48% | ASTELLAS PHARMA INC SEDOL 6985383 | 0.47% | NEKTAR THERAPEUTICS SEDOL 2454445 | 0.45% | CHUGAI PHARMACEUTICAL CO LTD SEDOL 6196408 | 0.42% | BIODESIX INC SEDOL BMWXS28 | 0.31% | POPULATION HEALTH INVESTMENT SEDOL BNDQB91 | 0.30% | SYNDAX PHARMACEUTICALS INC SEDOL BN7Q7R7 | 0.27% | EISAI CO LTD SEDOL 6307200 | 0.25% | TRULIEVE CANNABIS CORP SEDOL BGNKTH8 | 0.25% | COLUMBIA CARE INC SEDOL BJYS701 | 0.24% | GREEN THUMB INDUSTRIES INC SEDOL BFFY829 | 0.24% | TREASURY BILL 00.0000 05/13/2021 | 0.13% | LIFESCI ACQUISITION COR-CW25 SEDOL BNGJR33 | 0.12% | CHF/USD 06/16/2021 JPMCB | 0.07% | CASH MGMT BILL 00.0000 06/29/2021 | 0.06% | JPY/USD 05/19/2021 BANKAM | 0.05% | JPY/USD 05/19/2021 JPMCB | 0.05% | GBP/USD 06/16/2021 WPAC | 0.04% | AUD/USD 04/21/2021 UBS | 0.03% | EUR/USD 06/16/2021 HSBCB | 0.03% | GBP/USD 06/16/2021 CSI-FX | 0.02% | GBP/USD 06/16/2021 SSBT | 0.02% | EUR/USD 06/16/2021 MSCIL | 0.02% | EUR/USD 06/16/2021 GSFX | 0.01% | GBP/USD 06/16/2021 BANKAM | 0.01% | JPY/USD 05/19/2021 SSBT | 0.01% | EUR/USD 06/16/2021 CITI | 0.00% | GBP/USD 06/16/2021 BCAP-FX | 0.00% | GBP/USD 06/16/2021 HSBCB | 0.00% | EUR/USD 06/16/2021 UBS | 0.00% | CAD/USD 04/21/2021 SSBT | 0.00% | EUR/USD 06/16/2021 SSBT | 0.00% | NEURALSTEM INC SERIES K COMMON STOCK PURCHASE WARRANT | 0.00% | EUR/USD 06/16/2021 WPAC | -0.00% | ILS/USD 04/21/2021 SSBT | -0.00% | EUR/USD 06/16/2021 TDBK | -0.00% | EUR/USD 06/16/2021 BCAP-FX | -0.01% | AUD/USD 04/21/2021 SSBT | -0.01% | NZD/USD 04/21/2021 JPMCB | -0.01% | AUD/USD 04/21/2021 JPMCB | -0.01% | GBP/USD 06/16/2021 GSFX | -0.01% | JPY/USD 05/19/2021 BCAP-FX | -0.01% | EUR/USD 06/16/2021 RBSF | -0.01% | AUD/USD 04/21/2021 WPAC | -0.01% | GBP/USD 06/16/2021 MSCIL | -0.02% | CHF/USD 06/16/2021 HSBCB | -0.03% | CHF/USD 06/16/2021 MSCIL | -0.03% | JPY/USD 05/19/2021 UBS | -0.03% | JPY/USD 05/19/2021 CSI-FX | -0.04% | AUD/USD 04/21/2021 RBSF | -0.05% | EUR/USD 06/16/2021 BANKAM | -0.05% | DKK/USD 06/16/2021 CITI | -0.05% | JPY/USD 05/19/2021 GSFX | -0.13% |
Portfolio Composition as of 06/30/21
| Common stock | 96.92% |
| Cash and net other assets | 3.08% |
Consider these risks before investing: International investing involves currency, economic, and political risks. Emerging-market securities carry illiquidity and volatility risks. Investments in small and/or midsize companies increase the risk of greater price fluctuations. The health care industries may be affected by technological obsolescence, changes in regulatory approval policies for drugs, medical devices, or procedures, and changes in governmental and private payment systems. The fund concentrates on a limited group of industries and is non-diversified. Because the fund may invest in fewer issuers than a diversified fund, it is vulnerable to common economic forces and may result in greater losses and volatility. Growth stocks may be more susceptible to earnings disappointments, and value stocks may fail to rebound. The use of short selling may result in losses if the securities appreciate in value. Risks associated with derivatives include increased investment exposure (which may be considered leverage) and, in the case of over-the-counter instruments, the potential inability to terminate or sell derivatives positions and the potential failure of the other party to the instrument to meet its obligations. The value of investments in the fund’s portfolio may fall or fail to rise over extended periods of time for a variety of reasons, including general economic, political, or financial market conditions; investor sentiment and market perceptions; government actions; geopolitical events or changes; and factors related to a specific issuer, geography, industry, or sector. These and other factors may lead to increased volatility and reduced liquidity in the fund’s portfolio holdings. Our investment techniques, analyses, and judgments may not produce the outcome we intend. The investments we select for the fund may not perform as well as other securities that we do not select for the fund. We, or the fund’s other service providers, may experience disruptions or operating errors that could have a negative effect on the fund. You can lose money by investing in the fund. Variable annuities are long-term investments designed for retirement purposes. Withdrawals prior to age 59 1/2 may be subject to a 10% IRS penalty.
Top Industry Sectors as of 06/30/21
| Pharmaceuticals | 39.60% |
|---|---|
| Biotechnology | 20.08% |
| Health Care Equipment & Supplies | 13.69% |
| Health Care Providers & Services | 13.50% |
| Life Sciences Tools & Services | 8.55% |
| Cash and net other assets | 3.08% |
| Diversified Financial Services | 1.50% |
0
Country Allocation as of 06/30/21
| United States | 70.31% |
|---|---|
| United Kingdom | 6.95% |
| Switzerland | 6.20% |
| Denmark | 3.39% |
| France | 3.18% |
| Cash and net other assets | 3.08% |
| Japan | 2.87% |
| Ireland | 1.90% |
| Germany | 0.95% |
| Other | 1.17% |
0
Expenses
Sales Charges/Fees
| Breakpoint | Sales Charge | Dealer Allowance | CDSC Liab |
|---|---|---|---|
| $0 - $0 | 0.00% | 0.00% | N |
CDSC
| Year | Percent |
|---|---|
| 1 | 8.00% |
| 2 | 8.00% |
| 3 | 8.00% |
| 4 | 7.00% |
| 5 | 6.00% |
| 6 | 5.00% |
| 7 | 4.00% |
| 8 | 3.00% |
| 9+ | 0.00% |